Literature DB >> 3106981

Somatic diversification of S107 from an antiphosphocholine to an anti-DNA autoantibody is due to a single base change in its heavy chain variable region.

A M Giusti, N C Chien, D J Zack, S U Shin, M D Scharff.   

Abstract

The S107 myeloma cell line expresses the germ-line sequence of the T15 antiphosphocholine (P-Cho) antibody, which is the major antibody made by BALB/c mice in response to P-Cho, either on a variety of bacterial polysaccharides or when attached to a protein carrier. We have previously reported that a somatic mutant of the S107 cell line produces an antibody that has lost the ability to bind P-Cho and has acquired binding for double-stranded DNA. This antibody has a substitution of an alanine for a glutamic acid at residue 35 in the heavy chain variable region. We now show that this amino acid substitution is due to a single A-C transversion, which is the only nucleotide change in the heavy and light chain variable regions. Further, it appears that this change is due to somatic mutation rather than to gene conversion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106981      PMCID: PMC304773          DOI: 10.1073/pnas.84.9.2926

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  One heavy chain variable region gene segment subfamily in the BALB/c mouse contains 500-1000 or more members.

Authors:  D Livant; C Blatt; L Hood
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production.

Authors:  M Reth; P Gehrmann; E Petrac; P Wiese
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

3.  High rate of somatic point mutation in vitro in and near the variable-region segment of an immunoglobulin heavy chain gene.

Authors:  J Meyer; H M Jäck; N Ellis; M Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma.

Authors:  R Kleinfield; R R Hardy; D Tarlinton; J Dangl; L A Herzenberg; M Weigert
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

5.  Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression.

Authors:  R A Zeff; J Gopas; E Steinhauer; T V Rajan; S G Nathenson
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

6.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

7.  Antibody diversity: somatic hypermutation of rearranged VH genes.

Authors:  S Kim; M Davis; E Sinn; P Patten; L Hood
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

8.  Use of anti-idiotypic antibodies to explore genetic mechanisms of production of anti-DNA antibodies.

Authors:  A Davidson; N Chien; L Frank; R Halpern; S Snapper; K Zupko; B Diamond
Journal:  Cell Immunol       Date:  1986-04-15       Impact factor: 4.868

9.  VHDJH formation and DJH replacement during pre-B differentiation: non-random usage of gene segments.

Authors:  M G Reth; S Jackson; F W Alt
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

10.  Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies.

Authors:  J L Claflin; J M Davie
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  14 in total

1.  Altered reactivity of immunoglobulin produced by human-human hybridoma cells transfected by pSV2-neo gene.

Authors:  H Tachibana; K Akiyama; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-07       Impact factor: 2.058

2.  Identification of mutant monoclonal antibodies with increased antigen binding.

Authors:  R R Pollock; D L French; M L Gefter; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Somatic diversification of the S107 (T15) VH11 germ-line gene that encodes the heavy-chain variable region of antibodies to double-stranded DNA in (NZB x NZW)F1 mice.

Authors:  S M Behar; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 4.  Cross-reacting idiotypes on cryoprecipitating rheumatoid factor.

Authors:  P P Chen; S Fong; F Goni; G J Silverman; R I Fox; M F Liu; B Frangione; D A Carson
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Expression studies of catalytic antibodies.

Authors:  H D Ulrich; P A Patten; P L Yang; F E Romesberg; P G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

6.  Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus.

Authors:  B P Tsao; F M Ebling; C Roman; N Panosian-Sahakian; K Calame; B H Hahn
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

7.  Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.

Authors:  Masahide Yano; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2010-11-10

8.  The relationship between induced and spontaneous autoantibodies in MRL mice: the role of Ly-1 B cells?

Authors:  A Bond; F C Hay; A Cooke
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

9.  Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism.

Authors:  N C Chien; V A Roberts; A M Giusti; M D Scharff; E D Getzoff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Covalent binding antibodies suppress advanced glycation: on the innate tier of adaptive immunity.

Authors:  T Shcheglova; S P Makker; A Tramontano
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.